These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17565663)

  • 1. In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors.
    Jin ZH; Josserand V; Foillard S; Boturyn D; Dumy P; Favrot MC; Coll JL
    Mol Cancer; 2007 Jun; 6():41. PubMed ID: 17565663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4.
    Jin ZH; Furukawa T; Galibert M; Boturyn D; Coll JL; Fukumura T; Saga T; Dumy P; Fujibayashi Y
    Nucl Med Biol; 2011 May; 38(4):529-40. PubMed ID: 21531290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive optical imaging of ovarian metastases using Cy5-labeled RAFT-c(-RGDfK-)4.
    Jin ZH; Josserand V; Razkin J; Garanger E; Boturyn D; Favrot MC; Dumy P; Coll JL
    Mol Imaging; 2006 Jul; 5(3):188-97. PubMed ID: 16954034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.
    Shuhendler AJ; Prasad P; Leung M; Rauth AM; Dacosta RS; Wu XY
    Adv Healthc Mater; 2012 Sep; 1(5):600-8. PubMed ID: 23184795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo noninvasive optical imaging of receptor-mediated RGD internalization using self-quenched Cy5-labeled RAFT-c(-RGDfK-)(4).
    Jin ZH; Razkin J; Josserand V; Boturyn D; Grichine A; Texier I; Favrot MC; Dumy P; Coll JL
    Mol Imaging; 2007; 6(1):43-55. PubMed ID: 17311764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4.
    Jin ZH; Furukawa T; Degardin M; Sugyo A; Tsuji AB; Yamasaki T; Kawamura K; Fujibayashi Y; Zhang MR; Boturyn D; Dumy P; Saga T
    Mol Cancer Ther; 2016 Sep; 15(9):2076-85. PubMed ID: 27422811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins.
    Morlieras J; Dufort S; Sancey L; Truillet C; Mignot A; Rossetti F; Dentamaro M; Laurent S; Vander Elst L; Muller RN; Antoine R; Dugourd P; Roux S; Perriat P; Lux F; Coll JL; Tillement O
    Bioconjug Chem; 2013 Sep; 24(9):1584-97. PubMed ID: 23978076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging.
    Briat A; Wenk CH; Ahmadi M; Claron M; Boturyn D; Josserand V; Dumy P; Fagret D; Coll JL; Ghezzi C; Sancey L; Vuillez JP
    Cancer Sci; 2012 Jun; 103(6):1105-10. PubMed ID: 22448775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging.
    Goutayer M; Dufort S; Josserand V; Royère A; Heinrich E; Vinet F; Bibette J; Coll JL; Texier I
    Eur J Pharm Biopharm; 2010 Jun; 75(2):137-47. PubMed ID: 20149869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors.
    Garanger E; Boturyn D; Jin Z; Dumy P; Favrot MC; Coll JL
    Mol Ther; 2005 Dec; 12(6):1168-75. PubMed ID: 16051524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted radionuclide therapy with RAFT-RGD radiolabelled with (90)Y or (177)Lu in a mouse model of αvβ3-expressing tumours.
    Bozon-Petitprin A; Bacot S; Gauchez AS; Ahmadi M; Bourre JC; Marti-Batlle D; Perret P; Broisat A; Riou LM; Claron M; Boturyn D; Fagret D; Ghezzi C; Vuillez JP
    Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):252-63. PubMed ID: 25164771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the αvβ₃ integrin tracer ⁶⁴Cu-labeled cyclam-RAFT-c(-RGDfK-)₄.
    Aung W; Jin ZH; Furukawa T; Claron M; Boturyn D; Sogawa C; Tsuji AB; Wakizaka H; Fukumura T; Fujibayashi Y; Dumy P; Saga T
    Mol Imaging; 2013 Sep; 12(6):376-87. PubMed ID: 23981783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time near-infrared fluorescence imaging using cRGD-ZW800-1 for intraoperative visualization of multiple cancer types.
    Handgraaf HJM; Boonstra MC; Prevoo HAJM; Kuil J; Bordo MW; Boogerd LSF; Sibinga Mulder BG; Sier CFM; Vinkenburg-van Slooten ML; Valentijn ARPM; Burggraaf J; van de Velde CJH; Frangioni JV; Vahrmeijer AL
    Oncotarget; 2017 Mar; 8(13):21054-21066. PubMed ID: 28416744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.
    Beer AJ; Haubner R; Sarbia M; Goebel M; Luderschmidt S; Grosu AL; Schnell O; Niemeyer M; Kessler H; Wester HJ; Weber WA; Schwaiger M
    Clin Cancer Res; 2006 Jul; 12(13):3942-9. PubMed ID: 16818691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging and biodistribution analysis of the effects of succinylated gelatin combined with L-lysine on renal uptake and retention of ⁶⁴Cu-cyclam-RAFT-c(-RGDfK-)₄ in vivo.
    Jin ZH; Furukawa T; Sogawa C; Claron M; Aung W; Tsuji AB; Wakizaka H; Zhang MR; Boturyn D; Dumy P; Fujibayashi Y; Saga T
    Eur J Pharm Biopharm; 2014 Apr; 86(3):478-86. PubMed ID: 24316338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR dye: In vitro and in vivo evaluation.
    Choi J; Rustique E; Henry M; Guidetti M; Josserand V; Sancey L; Boutet J; Coll JL
    Int J Pharm; 2017 Nov; 532(2):677-685. PubMed ID: 28279737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 67Cu-Radiolabeling of a multimeric RGD peptide for αVβ3 integrin-targeted radionuclide therapy: stability, therapeutic efficacy, and safety studies in mice.
    Jin ZH; Furukawa T; Ohya T; Degardin M; Sugyo A; Tsuji AB; Fujibayashi Y; Zhang MR; Higashi T; Boturyn D; Dumy P; Saga T
    Nucl Med Commun; 2017 Apr; 38(4):347-355. PubMed ID: 28291159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
    Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L
    Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125.
    Kim YH; Jeon J; Hong SH; Rhim WK; Lee YS; Youn H; Chung JK; Lee MC; Lee DS; Kang KW; Nam JM
    Small; 2011 Jul; 7(14):2052-60. PubMed ID: 21688390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor.
    Adulnirath A; Chung SW; Park J; Hwang SR; Kim JY; Yang VC; Kim SY; Moon HT; Byun Y
    J Control Release; 2012 Nov; 164(1):8-16. PubMed ID: 23063549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.